Newsy's Latest Health News

The US government has partnered with AstraZeneca, committing up to $1.2 billion to expedite the development of a COVID-19 vaccine, aiming for 300 million doses by October and a phase three trial with 30,000 volunteers. HHS Secretary Alex Azar highlights this as a milestone for vaccine availability by 2021. Concurrently, the FDA is tightening regulations on COVID-19 antibody tests, approving only 12 companies while removing others from the market for not meeting application requirements.

What is the amount the federal government has agreed to pay to a drugmaker for the COVID-19 vaccine development?

Which drugmaker is the US Department of Health and Human Services working with to secure vaccine doses?

What is the expected availability date for the first doses of the vaccine?

How many volunteers are expected to participate in the phase three clinical trial of the vaccine?

How many companies has the FDA approved to distribute antibody tests so far?